Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

NetScientific hails commercial launch of breakthrough cancer detection device

The official launch took place in San Francisco at the Molecular Medicine Tri Conference.
NetScientific hails commercial launch of breakthrough cancer detection device
The fully-automated technology is able to collect circulating tumour cells
NetScientific PLC (LON:NSCI) said its investee company Vortex Biosciences has begun the commercial launch of its VTX1 Liquid Biopsy System.
 
The fully-automated technology offers a breakthrough in early cancer detection in that it is able to collect circulating tumour cells (CTC) from the bloodstream that provide the tell-tale sign of the killer disease.
 
"We believe the technology has several key advantages over current approaches to CTC isolation and has the potential to make a meaningful impact on cancer research and assist the development of innovative diagnostics and therapeutics," said NetScientific chief executive François Martelet. 
 
"The commercial launch is a critical milestone for Vortex and brings our portfolio company closer to significant value creation."
 
The AIM-listed investment company owns 95% of Votex having invested just over £13mln in the business.
 
The official launch took place in San Francisco at the Molecular Medicine Tri Conference.
 
Ian_55ae0ddd437b7.jpg
Why Invest In Netscientific PLC? Read More Here

Register here to be notified of future NSCI Company articles
View full NSCI profile

Netscientific PLC Timeline

Related Articles

GW_Pharma.png
January 11 2017
“[We are] entering a very exciting phase, which should result in the crystallisation of substantial value,” said chief executive, Dr Satu Vainikka.
Bankroll.jpg
March 01 2017
The new funds will be used to expand the pre-clinical and early-clinical development of the company’s immuno-oncology drug, Clevegen
shutterstock_216375733.jpg
January 24 2017
At the moment, the healthcare firm M Pharma is a work in progress

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use